Apomorphine Hydrochloride and Insulin Glargine (U-300) Pens
Determining the interaction of Apomorphine Hydrochloride and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: Apomorphine
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apomorphine Hydrochloride-Insulin glargine and lixisenatide
- Apomorphine Hydrochloride-Insulin glargine and lixisenatide Subcutaneous
- Apomorphine Hydrochloride-Insulin glargine, recombinant Subcutaneous
- Apomorphine Hydrochloride-Insulin glulisine
- Apomorphine Hydrochloride-Insulin Glulisine (Cartridges and Pens)
- Apomorphine Hydrochloride-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Apomorphine Subcutaneous
- Insulin Glargine (U-300) Pens-Apra
- Insulin Glargine (U-300) Pens-Apraclonidine
- Insulin Glargine (U-300) Pens-Apraclonidine Hydrochloride
- Insulin Glargine (U-300) Pens-Apraclonidine ophthalmic
- Insulin Glargine (U-300) Pens-Apremilast